Tag Archives: Next Gen RNA fragmentomics-based diagnostics

Santa Cruz, CA: RealSeq Biosciences, Inc., a company developing RNA fragmentomics as real-time diagnostics for disease was awarded a grant from the National Human Genome Research Institute (NHGRI) for the development of a new small RNA-seq NGS technology. The SBIR ...

Read More »